Cost-Effectiveness Analysis of Third-Generation Cephalosporin Antibiotics in the Treatment of Typhoid Fever at Tangerang Selatan General Hospital

Mochammad Widya Pratama, Gandes Winarni, Luthfinawa Ayu Utari

Abstract


Typhoid fever is an acute systemic infectious disease caused by Salmonella typhi bacteria that infect through contaminated food or drink. In the treatment of typhoid fever, antibiotic therapy is needed. Third-generation cephalosporin antibiotics are antibiotics used as second-line treatment in typhoid fever. Differences in antibiotic use can increase costs incurred by patients, so a cost-effectiveness analysis is needed to determine the most effective and efficient treatment. The purpose of this study was to determine the cost effectiveness of third-generation cephalosporin antibiotics in patients with typhoid fever hospitalized in South Tangerang City Hospital in 2023. The research method in this study is descriptive method with purposive sampling technique. This research design uses a non-experimental design. This study was conducted in April-May 2024 at the South Tangerang City Hospital using secondary data in the form of medical record data and medical cost data as research instruments. The number of samples in this study were 127 samples that met the inclusion criteria. The third-generation cephalosporin antibiotics used were ceftriaxone and cefixime. Cost-effectiveness is expressed in ACER (Average Cost-Effectiveness Ratio) which is obtained from the average total direct medical costs divided by the average clinical outcome. The results showed the ACER value of cefixime Rp.767,866/day for length of hospitalization and Rp.1,122,611/day for fever-free time, ACER value of ceftriaxone Rp.711,349/day for length of hospitalization and Rp.985,726/day for fever-free time, ACER value of ceftriaxone + cefixime antibiotic combination Rp.763,054/day for length of hospitalization and Rp.1,051.146/day for fever-free time. The conclusion of this study is that the most cost-effective third-generation cephalosporin antibiotic is ceftriaxone.

Keywords


Typhoid fever; Cost-effectiveness analysis; Third-generation cephalosporins; Ceftriaxone; Cefixime

Full Text:

PDF

References


D. N. Siahaan, F. Hasanah, E. S. Dasopang, and R. A. Ndruru, "Review: Analisis Efektivitas Biaya Penggunaan Antibiotik pada Pasien Demam Tiphoid Anak di Indonesia," Journal of Pharmaceutical and Sciences, vol. 5, no. 1, pp. 146–155, 2022. [Online]. Available: https://doi.org/10.36490/journal-jps.com.v5i1.146

M. I. Fahlevi, "Hubungan Lingkungan dan Sanitasi Makanan dengan Kejadian Demam Thypoid," Jurnal Seminar Nasional Teknologi Komputer & Sains (SAINTEKS), pp. 140–143, 2019. [Online]. Available: https://ejurnal.lppmunsera.org/index.php/SAINTEKS/article/view/2019

A. Gunawan, I. A. Rahman, A. Nurapandi, N. C. Maulana, and S. Muhammadiyah, "Hubungan Personal Hygiene dengan Kejadian Demam Typhoid pada Remaja di Wilayah Kerja Puskesmas Imbanagara Kabupaten Ciamis," Healthcare Nursing Journal, vol. 4, no. 2, pp. 404–412, 2022. [Online]. Available: https://doi.org/10.34035/hnj.v4i2.1000

N. M. D. P. Dewi, R. K. Illahi, Lyrawati, and Diana, "Analisis Cost-Effectiveness Penggunaan Antibiotik Kloramfenikol, Seftriakson dan Sefiksim sebagai Terapi Demam Tifoid Anak," Pharmaceutical Journal of Indonesia, vol. 5, no. 1, pp. 53–59, 2019. [Online]. Available: https://doi.org/10.21776/ub.pji.2019.005.01.7

D. Indriani et al., "Analisis Efektivitas Biaya Penggunaan Antibiotik Seftriakson dan Sefotaksim pada Terapi Demam Tifoid di RSUD Dr. M.Ashari Pemalang," Jurnal Medika Nusantara, vol. 1, no. 2, pp. 240–251, 2023. [Online]. Available: https://doi.org/10.36989/jmn.v1i2.123

Z. Islam, S. Hastuti, R. Mansur, and Rahmania, "Analisis Efektivitas Biaya Penggunaan Cefiksim dan Ceftriakson pada Pasien Pneumonia," Majalah Farmasi dan Farmakologi, pp. 11–14, 2023. [Online]. Available: https://doi.org/10.1234/mff.v1i1.567

Y. Yusransyah, Y. Rahmawati, B. Udin, and N. M. Kurnia, "Cost-Effectiveness Analysis of Ceftriaxone and Cefixime in Typhoid Fever Patients Hospitalized at Berkah Pandeglang Regional Hospital for the Period 2020-2021," Jurnal Farmasi Sains dan Praktis, vol. 9, no. 2, pp. 178–184, 2023. [Online]. Available: https://doi.org/10.31603/pharmacy.v9i2.2023

F. M. Asyari, C. A. Aprilia, Bahar, and Meiskha, "Analisis Efektivitas Biaya Penggunaan Antibiotik Seftriakson dan Sefotaksim pada Pasien Rawat Inap Demam Tifoid Anak di RSUD Depok Tahun 2017-2018," in Seminar Nasional Riset Kedokteran, 2020. [Online]. Available: https://conference.upnvj.ac.id/index.php/sensorik/article/view/441

D. N. Siahaan, F. Hasanah, E. S. Dasopang, and R. A. Ndruru, "Analisis Efektivitas Biaya Penggunaan Antibiotik pada Pasien Demam Tiphoid Anak di Indonesia," Journal of Pharmaceutical and Sciences, vol. 5, no. 1, pp. 146–155, 2022. [Online]. Available: https://doi.org/10.36490/journal-jps.com.v5i1.146

A. Gunawan, I. A. Rahman, A. Nurapandi, and N. C. Maulana, "Hubungan Personal Hygiene dengan Kejadian Demam Typhoid pada Remaja di Wilayah Kerja Puskesmas Imbanagara Kabupaten Ciamis," Healthcare Nursing Journal, vol. 4, no. 2, pp. 404–412, 2022. [Online]. Available: https://doi.org/10.34035/hnj.v4i2.1000

N. M. D. P. Dewi, "Analisis Cost Effectiveness Penggunaan Antibiotik Kloramfenikol, Seftriakson, dan Sefiksim sebagai Terapi Demam Tifoid Anak (Studi Dilakukan di Instalasi Rawat Inap Rumah Sakit Karsa Husada Kota Batu)," PhD Thesis, Universitas Brawijaya, 2019. [Online]. Available: http://repository.ub.ac.id/175375/

D. Indriani, M. F. Fatkhiya, and G. Ulistanti, "Analisis Efektivitas Biaya Penggunaan Antibiotik Seftriakson dan Sefotaksim pada Terapi Demam Tifoid di RSUD Dr. M. Ashari Pemalang," Jurnal Medika Nusantara, vol. 1, no. 2, pp. 240–251, 2023. [Online]. Available: https://ejurnal.stikesmhk.ac.id/index.php/medikanusantara/article/view/240

F. M. Asyari, C. A. Aprilia, and M. Bahar, “ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN ANTIBIOTIK SEFTRIAKSON DAN SEFOTAKSIM PADA PASIEN RAWAT INAP DEMAM TIFOID ANAK DI RSUD DEPOK TAHUN 2017-2018,” in Seminar Nasional Riset Kedokteran, 2020. Accessed: Feb. 10, 2025. [Online]. Available: https://conference.upnvj.ac.id/index.php/sensorik/article/view/441

R. I. Kemenkes, Pedoman Penerapan Kajian Farmakoekonomi, Jakarta: Kementerian Kesehatan Republik Indonesia, vol. 6, 2013. [Online]. Available: https://farmalkes.kemkes.go.id/2013/12/pedoman-penerapan-kajian-farmakoekonomi/

Y. Yusransyah, Y. Rahmawati, B. Udin, and N. M. Kurnia, "Cost-Effectiveness Analysis of Ceftriaxone and Cefixime in Typhoid Fever Patients Hospitalized at Berkah Pandeglang Regional Hospital for the Period 2020-2021," Jurnal Farmasi Sains dan Praktis, vol. 9, no. 2, pp. 178–184, 2023. [Online]. Available: https://doi.org/10.31603/pharmacy.v9i2.7050

R. Simanullang, T. M. Andayani, and C. Wiedyaningsih, "Estimasi Biaya Penyakit COVID-19 Rawat Inap di RSUP Dr. Sardjito Yogyakarta: Direct Medical Cost," Majalah Farmaseutik, vol. 19, no. 3, pp. 361–369. [Online]. Available: https://jurnal.ugm.ac.id/majalahfarmaseutik/article/view/64918

P. Indriyani, N. R. A. Harahap, W. Hasmar, and Nuraini, "Evaluasi Penggunaan Antibiotik pada Pasien Demam Tifoid di Rumah Sakit X Swasta Bekasi pada Tahun 2020," Jurnal Mitra Kesehatan, vol. 4, no. 2, pp. 108–113, 2022. [Online]. Available: https://doi.org/10.24912/jmk.v4i2.15088

T. S. Tuloli, "Cost-Effectiveness Analysis Terapi Antibiotik Seftriakson dan Sefotaksim pada Pasien Tifoid di RSUD Dr. M.M Dunda Limboto," Jurnal Entropi, vol. 12, no. 1, pp. 97–103, 2017. [Online]. Available: https://ejurnal.ung.ac.id/index.php/entropi/article/view/2774

H. N. Siregar, "Analisis Efektivitas Biaya Penggunaan Antibiotik Seftriakson dan Sefotaksim pada Pasien Pneumonia Komunitas Bayi dan Balita di Instalasi Rawat Inap Rumah Sakit Umum Pusat Fatmawati Tahun 2017-2018," PhD Thesis, Universitas Pembangunan Nasional Veteran Jakarta, 2020. [Online]. Available: https://repository.upnvj.ac.id/18144/

N. Jannah and M. R. Tandah, "Efektivitas Biaya Penggunaan Seftriakson dan Sefiksim pada Pasien Demam Tifoid Rawat Inap di RSU Anutapura Palu Periode 2015-2017," Jurnal Ilmiah Medicamento, vol. 5, no. 1, 2019. [Online]. Available: https://ejurnal.untad.ac.id/index.php/medicamento/article/view/768

R. Sunaryani, A. Mukaddas, and M. R. Tandah, "Perbandingan Efektivitas Antibiotik Golongan Sefalosporin Generasi Ketiga pada Pasien Demam Tifoid di Rumah Sakit Daerah Madani Provinsi Sulawesi Tengah Periode 2017," Jurnal Ilmiah Medicamento, vol. 5, no. 1, pp. 58–62, 2019. [Online]. Available: https://ejurnal.ung.ac.id/index.php/medicamento/article/view/329061

M. Amanda and M. Shoaliha, "Efektivitas Biaya Medis Langsung Penggunaan Antibiotik Golongan Sefalosporin Generasi Ketiga pada Pasien Tifoid di Rumah Sakit Rawa Lumbu," Lumbung Farmasi: Jurnal Ilmu Kefarmasian, vol. 4, no. 2, pp. 321–327, 2023. [Online]. Available: https://jurnal.lppm.unsoed.ac.id/ojs/index.php/lf/article/view/13130

F. M. Asyari, C. A. Aprilia, and M. Bahar, "Analisis Efektivitas Biaya Penggunaan Antibiotik Seftriakson dan Sefotaksim pada Pasien Rawat Inap Demam Tifoid Anak di RSUD Depok Tahun 2017-2018," in Seminar Nasional Riset Kedokteran, 2020. [Online] Available: https://conference.upnvj.ac.id/index.php/sensorik/article/view/441

T. S. Tuloli, "Cost-Effectiveness Analysis Terapi Antibiotik Seftriakson dan Sefotaksim pada Pasien Tifoid di RSUD Dr. M.M Dunda Limboto," Jambura Journal of Educational Chemistry, vol. 12, no. 1, pp. 97–103, 2017. [Online]. Available: https://ejurnal.ung.ac.id/index.php/jec/article/view/277411

M. Amanda and M. Shoaliha, "Efektivitas Biaya Medis Langsung Penggunaan Antibiotik Golongan Sefalosporin Generasi Ketiga pada Pasien Tifoid di Rumah Sakit Rawa Lumbu," Jurnal Ilmu Kefarmasian, vol. 4, no. 2, pp. 321–327, 2023. [Online]. Available: https://jurnal.lppm.unsoed.ac.id/ojs/index.php/lf/article/view/13130

Nurleli and N. Rahmi, "Pengaruh Umur dan Jenis Kelamin terhadap Kejadian Demam Tifoid pada Pasien Rawat Inap di Rumah Sakit Tingkat II Iskandar Muda Kota Banda Aceh," Journal of Healthcare Technology and Medicine, vol. 9, no. 2, pp. 1140–1147, 2023. [Online]. Available: https://ejurnal.ung.ac.id/index.php/jhtm/article/view/1140

Jonnefi, "Implementasi Clinical Pathway dengan Analisa Penggunaan Antibiotika, Pasien Anak dengan Demam Tifoid Rawat Inap," Jurnal Health Sains, vol. 4, no. 3, pp. 62–73, 2023. [Online]. Available: https://journal.universitaspahlawan.ac.id/index.php/healthsains/article/view/35556

S. Rachmawati, D. K. Masito, and Ema, "Evaluasi Penggunaan Antibiotik pada Pasien Anak Rawat Inap di RSD Dr. Soebandi Jember," Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), vol. 6, no. 2, pp. 212–220, 2020. [Online]. Available: https://jurnal.unej.ac.id/index.php/JFG/article/view/9819

M. R. Andarsari et al., "Analisis Efektivitas Biaya Penggunaan Antibiotika pada Pasien Demam Tifoid," Jurnal Farmasi Higea, vol. 16, no. 1, pp. 63–71, 2024. [Online]. Available: https://journal.unair.ac.id/HIG@analisis-efektivitas-biaya-penggunaan-antibiotika-pada-pasien-demam-tifoid-article-17535.html

S. N. Hidayah, A. Hakim, A. Syahrir, and W. Anggraini, "Analisis Efektivitas Biaya Seftriakson dan Sefotaksim pada Pasien Demam Tifoid Anak di Instalasi Rawat Inap Shofa dan Marwah PKU Karangasem Muhammadiyah Paciran Tahun 2019," Journal of Islamic Pharmacy, vol. 5, no. 2, pp. 46–52, 2020. [Online]. Available: http://etheses.uin-malang.ac.id/19932/

• A. R. Dahlan, M. Aminyoto, and Muhyi, "Faktor yang Berhubungan dengan Lama Rawat Inap pada Balita dengan Diare Akut di RSUD Abdoel Wahab Sjahranie Samarinda," Majalah Kesehatan, vol. 9, no. 4, pp. 214–224, 2022. [Online]. Available: https://jurnal.fkmulmul.ac.id/index.php/mk/article/view/214

A. Rahmawati, H. Muchtar, Nasif, and Hansen, "Efektivitas Antibiotik pada Pasien Demam Tifoid di RSUP Dr. M. Djamil Padang," Journal of Pharmacy and Science, vol. 2, no. 2, pp. 13–28, 2019. [Online]. Available: https://jps.farmasi.unand.ac.id/index.php/jps/article/view/13

F. Oktaviana and P. Noviana, "Efektivitas Terapi Antibiotika Demam Tifoid pada Pediatrik di Rumah Sakit X Kota Kediri," Journal Syifa Sciences and Clinical Research, vol. 3, no. 2, pp. 63–70, 2021. [Online]. Available: https://jurnal.syifa.ac.id/index.php/syifa/article/view/63

Kementerian Kesehatan Republik Indonesia, Pedoman Penerapan Kajian Farmakoekonomi, Jakarta: Kementerian Kesehatan Republik Indonesia, 2013. [Online]. Available: https://farmalkes.kemkes.go.id/2013/06/pedoman-penerapan-kajian-farmakoekonomi/

R. Simanullang, T. M. Andayani, and C. Wiedyaningsih, "Estimasi Biaya Penyakit COVID-19 Rawat Inap di RSUP Dr. Sardjito Yogyakarta: Direct Medical Cost," Majalah Farmaseutik, vol. 19, no. 3, pp. 361–369, 2023. [Online]. Available: https://journal.ugm.ac.id/majalahfarmaseutik/article/view/83529




DOI: https://doi.org/10.37311/ijpe.v5i1.30254

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Mochammad Widya Pratama, Gandes Winarni, Luthfinawa Ayu Utari

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.